Caris Life Sciences (CAI) Director Jon Halbert Receives RSU Award

What Happened

• Jon Halbert, a director of Caris Life Sciences, was granted 13,192 restricted stock units (RSUs) on August 14, 2026. The reported acquisition price is $0.00, reflecting a compensation award rather than an open-market purchase. The RSUs will vest in accordance with the applicable grant agreement.

Key Details

• Transaction date: 2026-08-14; transaction type: Award/Grant (code A).
• Shares/units granted: 13,192 RSUs; reported acquisition price: $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnotes in the filing:
  • F1: Award of RSUs that vest per the grant agreement.
  • F2: Includes shares received in pro rata distributions exempt under Rule 16a-9.
  • F3: Reporting person disclaims beneficial ownership except to the extent of pecuniary interest.
• Filing timeliness: Report lists the same transaction and report date (2026-08-14); no late filing is indicated.

Context

• RSU grants are a form of compensation and typically vest over time; they are not an immediate purchase signal of confidence like an open-market buy. Vesting schedules and any post-vesting sales would be reported later and can be more informative about insider sentiment. The disclaimers suggest limited beneficial ownership beyond economic interest.